BDNF (Brain-Derived Neurotrophic Factor)

Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family — proteins that promote the survival, development, and function of neurons. It is produced primarily by neurons and astrocytes throughout the brain, with the highest concentrations in the hippocampus and cerebral cortex. BDNF acts by binding to the TrkB receptor, activating signaling pathways that promote neuronal survival, axonal branching, synaptic strengthening, and hippocampal neurogenesis.

BDNF is the most widely studied molecular mechanism linking exercise to brain health. Aerobic exercise reliably and substantially elevates BDNF levels in the hippocampus and plasma, which is one reason exercise consistently shows among the strongest cognitive benefits of any lifestyle intervention. A landmark study by Erickson et al. (2011, PNAS) demonstrated that aerobic exercise training over one year increased hippocampal volume by 2% and elevated BDNF levels, compared to controls who showed the typical 1-2% age-related volume decline.

BDNF levels are reduced by chronic stress, sleep deprivation, a high-fat diet, social isolation, and aging. They are elevated by aerobic exercise, intermittent fasting, social engagement, learning new skills, and certain antidepressant medications. The Val66Met polymorphism in the BDNF gene affects how efficiently BDNF is secreted in response to neural activity — people with the Met allele have reduced activity-dependent BDNF release and somewhat greater vulnerability to stress-related cognitive effects.

BDNF is considered a key molecular mediator of cognitive reserve. Higher BDNF levels support greater synaptic plasticity, more robust hippocampal neurogenesis, and better resilience of neural circuits to age-related and disease-related damage. Exercise is the most potent and accessible way to elevate BDNF, and this explains much of the cognitive benefit of regular aerobic exercise.

In Alzheimer's disease, BDNF levels are reduced in the hippocampus and cortex. Whether this reduction is a cause or a consequence of neurodegeneration — or both — is an active research question. Strategies that maintain BDNF levels through exercise and reduced chronic stress may slow the biological processes that contribute to Alzheimer's pathology, though clinical trial evidence directly attributing cognitive benefit to BDNF elevation is limited.

BDNF also mediates the antidepressant effects of exercise. Depression is both a risk factor for cognitive decline and often co-occurs with early Alzheimer's. Exercise-induced BDNF elevation in the hippocampus appears to be a key mechanism of the antidepressant effect of aerobic activity, providing a plausible biological link between the mood benefits of exercise and its cognitive benefits.